Search Results [15931 Hits] Selected Records [0 Hits] [Clear]
| Year | Source | Title | |
|---|---|---|---|
| 2007 | VA Technology Assessment Program (VATAP) | Bladder cancer surveillance | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [3 Tesla Magnetic Resonance Imaging] | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [Radiofrequency ablation of breast tumours] | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [AmpliChip CYP450: Cytochrome P450 genotyping in psychiatric patients] | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [Planned home birth. Current situation in developed countries] | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [Effectiveness of knee arthroscopy] | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [Selective screening for lung cancer with chest CT] | |
| 2007 | Andalusian Health Technology Assessment Area (AETSA) | [Transcutaneous biosensors] | |
| 2007 | VA Technology Assessment Program (VATAP) | Computerized tomography colonography | |
| 2007 | VA Technology Assessment Program (VATAP) | Stereotactic radiosurgery: update | |
| 2007 | VA Technology Assessment Program (VATAP) | Systematic reviews for patient-centered care | |
| 2007 | VA Technology Assessment Program (VATAP) | Systematic reviews of strategies for changing clinician behavior to improve patient outcomes | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Comparative effectiveness and safety of oral diabetes medications for adults with type 2 diabetes | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Comparative effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) for treating essential hypertension | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Comparative effectiveness of management strategies for renal artery stenosis: 2007 update | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis | |
| 2007 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Proton beam therapy for the treatment of uveal melanoma | |
| 2007 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Proton beam therapy for the treatment of neoplasms involving (or adjacent to) cranial structures | |
| 2007 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Autologous bone marrow cell transplantation for myocardial infarction | |
| 2007 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Intraoperative ultrasound for breast lesion localisation during breast conserving surgery (lumpectomy) | |
| 2007 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Genetic screening for familial hypercholesterolaemia | |
| 2007 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Sleeve gastrectomy as a single stage bariatric procedure | |
| 2007 | Institute for Clinical Evaluative Sciences (ICES) | Effectiveness and safety of drug-eluting stents in Ontario | |
| 2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Infliximab in patients with arthritis psoriatic: systematic review of the clinical and economic literature] | |
| 2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Parenteral methotrexate in patients with rheumatoid arthritis: systematic review, crossectional study and economic evaluation] | |
| 2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Economic evaluation of the first TNF-alpha inhibitor therapy in patients with rheumatoid arthritis] | |
| 2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Abatacept in the treatment of rheumatoid arthritis; systematic review and economic evaluation] | |
| 2007 | Quality Improvement Scotland (NHS QIS ) | Using data to improve surgical care - the surgical profiles project | |
| 2007 | Institute for Clinical Evaluative Sciences (ICES) | Quality assessment of administrative data (QuAAD): an opportunity for enhancing Ontario's health data | |
| 2007 | Institute for Clinical Evaluative Sciences (ICES) | The Ontario Wait Time Strategy: no evidence of an adverse impact on other surgeries | |
| 2007 | Institute for Clinical Evaluative Sciences (ICES) | Diagnostic services in Ontario: descriptive analysis and jurisdictional review | |
| 2007 | Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) | BRATS 03: Nucleic acids amplification tests (NAT) and other strategies for the detection of HIV-1 and HCV viruses in the selection of donated blood | |
| 2007 | Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) | [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards. 1. Information to users on breast cancer screening] | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Evidence for the reaffirmation of the U.S. Preventive Services Task Force recommendation on screening for high blood pressure | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Primary care interventions to prevent motor vehicle occupant injuries | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Screening for chlamydial infection: a focused evidence update for the U.S. Preventive Services Task Force | |
| 2007 | Agency for Healthcare Research and Quality (AHRQ) | Screening for human immunodeficiency virus: focused update of a 2005 systematic evidence review for the U.S. Preventive Services Task Force | |
| 2007 | NIHR Health Technology Assessment programme | The effectiveness and cost-effectiveness of natalizumab for multiple sclerosis: an evidence review of the submission from Biogen | |
| 2007 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Effectiveness and safety of positron emission tomography in breast cancer] | |
| 2007 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Bilateral cochlear implants in children: effectiveness, safety and cost. Situation in the Spanish regions] | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Genetic Screening for hypertrophic cardiomyopathy | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Bladderchek: diagnostic test for bladder cancer | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Vertebral assessment with DEXA | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Point-of-care influenza tests | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Niobe magnetic navigation system for percutaneous coronary interventions | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Affymetrix DNA microarrays | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Brahms PCT assays for the diagnosis of systemic bacterial infection | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | VNS therapy system for the treatment of depression | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Earpopper™ for the treatment of otitis media in children | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Dasatinib (Sprycel®) for the treatment of Lymphoid blast CML and PH+ ALL | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Dasatinib (Sprycel®) for the treatment of chronic, accelerated or blast phase chronic myeloid leukaemia | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Vinorelbine (Navelbine Oral®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Idursulfase (Elaprase®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Agalsidase alfa (Replagal®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Sunitinib (Sutent®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Darunavir (Prezista®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Tipranavir (Aptivus®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Co-careldopa intestinal gel (Duodopa®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Dexrazoxane (Savene®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Clofarabine (Evoltra®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Emtricitabine (Emtriva®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Emtricitabine/tenofovir DF (Truvada®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Parathyroid hormone (PTH) (Preotact®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Use of sorafenib (Nexavar®) for advanced renal cell carcinoma within NHS Wales | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Use of alglucosidase alfa (Myozyme™) within NHS Wales | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Use of sodium phenylbutyrate within NHS Wales | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Laronidase (Aldurazyme®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Enfuvirtide | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Anagrelide (Xagrid®) | |
| 2007 | All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) | Use of iloprost trometamol (Ventavis®) within NHS Wales | |
| 2007 | Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) | [Interdisciplinary follow-up with actors in primary health care] | |
| 2007 | Health Technology and Policy Unit (HTPU) | Double Balloon Endoscopy/Enteroscopy (DBE) for the diagnosis and treatment of conditions of the small intestine | |
| 2007 | Health Technology and Policy Unit (HTPU) | Photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH) | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Implantable miniature telescope for macular degeneration | |
| 2007 | Adelaide Health Technology Assessment (AHTA) | Magnetic resonance imaging for the detection of foetal abnormalities | |
| 2007 | Basque Office for Health Technology Assessment (OSTEBA) | [Clinical practice guideline on low back pain] | |
| 2007 | Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) | [Exenatide in diabetes mellitus type 2 - Rapid report] | |
| 2007 | Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) | [Hyperbaric oxygen therapy for burns] | |
| 2007 | Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) | [Evidence-based patient information on chronic obstructive airway diseases - Asthma] | |
| 2007 | Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) | [Expertise on endometriosis] | |
| 2007 | Canary Health Service | [Cost-effectiveness analysis and health outcomes in orthopedic surgery of the hip and knee] | |
| 2007 | Canary Health Service | [Dynamometry and simultaneous surface electromyography in the identification of nonspecific low back pain and its reliability] | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Thoracoscopically assisted mitral valve surgery. NICE interventional procedures guidance 245 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates. NICE interventional procedures guidance 246 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Thoracoscopic excision of mediastinal parathyroid tumours. NICE interventional procedures guidance 247 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Thoracoscopic aortopexy for severe primary tracheomalacia. NICE interventional procedures guidance 243 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Grenz rays therapy for inflammatory skin conditions. NICE interventional procedures guidance 236 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Mini/micro screw implantation for orthodontic anchorage. NICE interventional procedures guidance 238 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Laparoscopic techniques for hysterectomy. NICE interventional procedures guidance 239 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Soft-palate implants for simple snoring. NICE interventional procedures guidance 240 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Soft-palate implants for obstructive sleep apnoea. NICE interventional procedures guidance 241 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain. NICE interventional procedures guidance 234 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children. NICE interventional procedures guidance 232 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Laparoscopic repair of abdominal aortic aneurysm. NICE interventional procedures guidance 229 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis. NICE interventional procedures guidance 230 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Therapeutic percutaneous image-guided aspiration of spinal cysts. NICE interventional procedures guidance 223 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Laparoscopic deroofing of simple renal cysts. NICE interventional procedures guidance 226 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Corneal implants for keratoconus. NICE interventional procedures guidance 227 | |
| 2007 | National Institute for Health and Care Excellence (NICE) | Corneal implants for the correction of refractive error. NICE interventional procedures guidance 225 |